Literature DB >> 9658586

Search for selective antagonists at alpha 1-adrenoreceptors: neutral or negative antagonism?

C Melchiorre1, M L Bolognesi, R Budriesi, A Chiarini, D Giardinà, A Minarini, W Quaglia, A Leonardi.   

Abstract

In this article the use of competitive antagonists as tools in receptor characterization and classification is discussed. It is pointed out that caution is required in receptor characterization because negative antagonism (inverse agonism) rather than neutral antagonism could play a relevant role. This implies that antagonists should be evaluated not only with regard to their affinity, but also with regard to their ability to affect the equilibrium between the two receptor states, namely active and inactive states. Since affinity and efficacy of a negative antagonist are system dependent the use of negative antagonists as competitive antagonists in receptor characterization may give rise to false differences in receptor subtypes. Finally, this article summarizes recent developments in the design of new alpha 1-adrenoreceptor antagonists which are structurally related to prazosin or WB 4101.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9658586     DOI: 10.1016/s0014-827x(98)00022-6

Source DB:  PubMed          Journal:  Farmaco        ISSN: 0014-827X


  2 in total

1.  Chiral analogues of (+)-cyclazosin as potent α1B-adrenoceptor selective antagonist.

Authors:  Gianni Sagratini; Michela Buccioni; Gabriella Marucci; Elena Poggesi; Matthew Skorski; Stefano Costanzi; Dario Giardinà
Journal:  Bioorg Med Chem       Date:  2018-05-17       Impact factor: 3.641

2.  Faster emergence behavior from ketamine/xylazine anesthesia with atipamezole versus yohimbine.

Authors:  Lukas Mees; Jonathan Fidler; Matthias Kreuzer; Jieming Fu; Machelle T Pardue; Paul S García
Journal:  PLoS One       Date:  2018-10-29       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.